Our latest press releases highlight the partnerships, research initiatives, and product innovations driving OMG Pharma’s vision for the future of medicinal cannabis. Discover how we are advancing science-led solutions designed to elevate patient care and support healthcare professionals.
Australian biotechnology company OMG Pharma, a division of the Oz Medicann Group, has announced the commencement of a world-first clinical study in partnership…
SYDNEY, Australia – OMG Pharma Australia (OMG), the scientific arm of the Oz Medicann Group and an architect in the Australian…
Sydney, Australia – May 18, 2024 – Oz Medicann Group, a leader in cannabinoid medicine and biotech innovation, is thrilled to…
SYDNEY, Australia – OMG Pharma Australia (OMG), the scientific arm of the Oz Medicann Group and an architect in the Australian…
Media enquiries: info@ozmedicann.com